Trial intelligence / Profile preview

PF-06273340 crossover analgesia study in healthy volunteers

NL-OMON40922Active, not recruiting

Sponsor
Pfizer
Start
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of PF-06273340 in chronic pain (5 arms), sponsored by Pfizer. Primary endpoints: Thermal pain (normal skin): pain detection threshold, Thermal pain (UVB skin): pain detection threshold and 3 more. Started Oct 2014; status: active, not recruiting.

02

Drugs

PF-06273340
03

Conditions

chronic pain

Beyond the preview

Go deeper on NL-OMON40922.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON40922.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call